Jasper Dingemanse

3 Patents

• US123369802025

  Dosing Regimen for a Selective S1P1 Receptor Agonist

  Vanda Pharmaceuticals Inc.

  0 cites
• US118344432023

  Crystalline Form of the Compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol

  Idorsia Pharmaceuticals Ltd

  0 cites
• US117716832023

  Dosing Regimen for a Selective S1P 1 Receptor Agonist

  Actelion Pharmaceuticals Ltd

  0 cites